Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
12/2012
12/25/2012US8338094 Reduced inhibition of one-step RT-PCR
12/25/2012US8337826 Active ingredient in a concentrate and a buffer; storage stability; free from human serum albumin
12/20/2012WO2012173422A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/20/2012WO2012172347A1 Diagnosing and treating inflammatory bowel disease and irritable bowel syndrome
12/20/2012WO2012172346A2 Treating respiratory conditions
12/20/2012WO2012172345A2 Treating conditions associated with allergy
12/20/2012WO2012172344A2 Treating conditions associated with sepsis
12/20/2012WO2012172343A2 Treating primary sclerosing cholangitis
12/20/2012WO2012172342A2 Treating multiple sclerosis
12/20/2012WO2012172340A2 Treating mental disorders
12/20/2012WO2012172339A2 Treating inflammatory arthritis
12/20/2012WO2012172337A2 Treating cardiovascular disease
12/20/2012WO2012172336A2 Treating inflammatory skin diseases
12/20/2012WO2012171429A1 Polyethylene glycol-interferon conjugate
12/20/2012US20120322977 Micropatterned multifunctional inorganic nanoparticle arrays based on patterned peptide constructs
12/20/2012US20120322134 Branched polymers
12/20/2012US20120322089 Sensitive and generic antibodies and multiple applications
12/20/2012US20120321697 Bpb-based cargo delivery system
12/20/2012US20120321660 Conjugation process of bacterial polysaccharides to carrier proteins
12/20/2012US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
12/20/2012US20120321658 Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins
12/20/2012US20120321630 Antibodies against g-csfr and uses thereof
12/20/2012US20120321617 Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle)
12/20/2012CA2838504A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
12/19/2012CN102834415A Filler for affinity chromatography and method for isolating immunoglobulin
12/19/2012CN102827365A Amino acid connected with polyethylene glycol and preparation method and application for amino acid
12/19/2012CN102827310A Photochemical initiation system and method for initiating photopolymerization or embedment of transparent system or nontransparent system by using same
12/19/2012CN102827284A Exendin or analogue containing polyethylene glycol group and preparation and application thereof
12/19/2012CN102827276A Antibody of cytochrome b5 type B and application thereof in purifying mitochondria
12/19/2012CN102824646A Conjugate of polyethylene glycol interferon
12/18/2012US8334367 T2R taste receptors and genes encoding same
12/18/2012US8334253 Cosmetic and dermatological formulations of MNTF peptides
12/18/2012US8333958 HSA-free formulations of interferon-Beta
12/13/2012WO2004070015A9 Nematode pan and zp receptor-like sequences
12/13/2012CA2837840A1 Protein-polymer-drug conjugates
12/12/2012CN102816234A Peptide, use of the peptide, method for production of the peptide, solid phase having the peptide immobilized thereon, and method for production of the solid phase
12/12/2012CN102816215A Smallish polypeptide capable of inhibiting HIV and medicinal use thereof
12/12/2012CN101511869B Anti-MCP-1 antibodies, compositions, methods and uses
12/11/2012US8329877 Methods for separating recombinant proteins in aqueous two-phase systems
12/11/2012US8329876 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
12/11/2012US8329870 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
12/11/2012US8329865 Antimicrobially active peptides
12/11/2012US8329860 Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation
12/11/2012US8329659 SAP variants and their use
12/11/2012US8329640 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (VIP) and their use for the treatment of lung diseases
12/11/2012US8329637 Immunosuppression and antigen-specific immune tolerance; allogenic organ rejection, graft versus host disease, type I diabetes, rheumatoid arthritis, multiple sclerosis, systemic lupus erithematosus; chronic inflammatory disease; Crohn's disease and ulcerative colitis; asthma
12/11/2012US8329393 Method for detecting and removing endotoxin
12/11/2012US8329185 Method for isolating and purifying grass pollen allergens
12/06/2012WO2012078559A3 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
12/06/2012US20120309943 Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier
12/06/2012US20120309936 Reducing the immunogenicity of fusion proteins
12/06/2012US20120308600 Polysaccharide immunogens conjugated to e. coli carrier proteins
12/06/2012CA2837710A1 Long-acting glp-1/glucagon receptor agonists
12/05/2012EP2529619A2 Treating neurological disorders
12/05/2012CN102812041A Compositions and Methods for Treatment of Ovarian Cancer
12/05/2012CN102807619A Compound containing immunoglobulin Fc segment and granulocyte macrophage-colony stimulating factor and pharmaceutical compositions of compound
12/04/2012US8324354 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
12/04/2012US8324347 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
12/04/2012US8324344 Membrane transduction peptides and methods of delivering material to a target cell
12/04/2012US8323918 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
12/04/2012US8323917 Method of screening for compounds that inhibit the enzymatic activity of GWT1 gene product
12/04/2012US8323912 Methods of screening heteromeric T1R2/T1R3 receptors which modulate sweet taste signaling
11/2012
11/29/2012WO2012159171A1 A system for the capture of a biological or chemical entity i
11/29/2012WO2012159170A1 A system for the capture of a biological or chemical entity ii
11/29/2012US20120301973 Clozapine immunoassay
11/29/2012US20120301480 H. pylori lipopolysaccharide outer core epitope
11/29/2012US20120301395 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
11/29/2012US20120301394 Targeting and in vivo imaging of tumor-associated macrophages
11/29/2012CA2837104A1 Amylin peptides and derivatives and uses thereof
11/28/2012EP2526118A1 Compositions and methods for treatment of ovarian cancer
11/28/2012EP2525828A2 Stabilized proteases for use in skin care
11/28/2012CN102803485A Modified biotin-conjugated protein
11/28/2012CN102802670A Stabilized proteases for use in skin care
11/28/2012CN102802669A Hydrophobins for dispersing active agents
11/28/2012CN102796196A Polyester-connected deuterohaemin-beta-Ala-His-Thr-Val-Glu-Lys (DhHP-6) and preparation method thereof
11/27/2012US8318659 Peptide-based organic sunscreens
11/27/2012US8318640 Methods for selective targeting
11/22/2012WO2012158445A1 Compositions and methods for the alteration of xlhed phenotypes
11/22/2012WO2012157339A1 Growth factor anchoring type bone graft material, method for producing growth factor anchoring type bone graft material, kit for producing growth factor anchoring type bone graft material, and method for forming bone
11/22/2012WO2012129423A3 Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295834 Opioid Prodrugs with Heterocyclic Linkers
11/22/2012US20120294885 Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds
11/22/2012US20120294848 IGE CH3 Peptide Vaccine
11/22/2012US20120294807 Fluorescent compounds
11/21/2012CN102791813A Surface-coated structures and methods
11/20/2012US8314211 Tissue sealant for use in non compressible hemorrhage
11/20/2012US8314208 Microwave enhanced N-fmoc deprotection in peptide synthesis
11/20/2012US8314069 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/20/2012US8313902 Magnetic fine particles having lower critical solution temperature
11/15/2012WO2012154735A2 Thermostable carbonic anhydrases and methods of use thereof
11/15/2012US20120289680 Chromatography ligand comprising domain c from staphylococcus aureus protein a for antibody isolation
11/14/2012CN102781965A Compositions and methods for the transport of therapeutic agents
11/13/2012US8309688 Monkey homolog of human oncostatin M and methods of use thereof
11/13/2012US8309687 Biomarker specific for cancer
11/13/2012US8309520 Fully synthetic albumin analog
11/13/2012US8309334 Method for producing highly impact-resistant granules
11/13/2012US8309306 Detection composition
11/13/2012CA2625156C Adjltvant compositions comprising a mineral salt and another immunostimulating compound
11/08/2012US20120283316 Delivery of Therapeutic Agents Using Oligonucleotide-Modified Nanoparticles As Carriers
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 107